Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan (Q36615283)

From Wikidata
Jump to navigation Jump to search
scientific article published on September 2005
edit
Language Label Description Also known as
English
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
scientific article published on September 2005

    Statements

    Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan (English)
    1 September 2005
    510-514

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit